Comprehensive 2025 Percutaneous Mechanical Circulatory Support Devices Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Percutaneous Mechanical Circulatory Support Devices Market Through 2025?
In recent times, there has been significant growth in the market size of percutaneous mechanical circulatory support devices. The industry, which is currently valued at $2.26 billion in 2024, is projected to increase to $2.46 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The increase seen over the historical period is largely due to the rising prevalence of cardiovascular diseases, an aging population, a surge in heart attacks, accelerated awareness and screening initiatives, as well as the heightened demand for heart pump apparatus.

What's the Projected Size of the Global Percutaneous Mechanical Circulatory Support Devices Market by 2029?
The market size for percutaneous mechanical circulatory support devices is anticipated to witness robust growth in the upcoming years and it will expand to $3.55 billion by 2029, at a compound annual growth rate (CAGR) of 9.5%. This surge during the projected period can be associated with an increased need for long-term mechanical circulatory support along with escalated healare expenditures, a rising number of diabetes and obesity cases, increased demand for heart transplants, and growing acceptance of percutaneous processes. The forecast period will also see major trends like pump tech advancements, medical technology progress, cardiac support tech developments, the rise of minimally invasive medical technologies, and the evolution of biocompatible materials.

View the full report here:
https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Top Growth Drivers in the Percutaneous Mechanical Circulatory Support Devices Industry: What's Accelerating the Market?
The escalating occurrence of cardiovascular diseases (CVDs) is projected to drive the expansion of the percutaneous mechanical circulatory support devices market in the future. CVDs consist of varied disorders that impact the heart and blood vessels, taking in conditions like coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The rising occurrence of these diseases can be linked to several factors such as growing aging population, poor lifestyle choices, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are utilized in managing cardiovascular diseases to enhance cardiac function, lessen strain on the heart, and aid recovery in critical heart conditions. For instance, figures from the Australian Institute of Health and Welfare displayed that doctor-certified deaths due to coronary heart disease (CHD) witnessed an increase to 14,100 in 2021 and rose further to 14,900 in 2022. Consequently, the escalating occurrence of cardiovascular diseases is sparking the growth of the percutaneous mechanical circulatory support (MCS) devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Trends Will Shape the Percutaneous Mechanical Circulatory Support Devices Market Through 2029 and Beyond?
Key businesses in the percutaneous mechanical circulatory support devices market are looking to enhance patient recovery and reduce surgical risks through the invention of cutting-edge solutions like intra-aortic axial-flow devices. These devices are a kind of percutaneous mechanical circulatory support (MCS) tool developed to enhance heart function by increasing the blood flow from the left ventricle to the aorta. As a recent example, the US-based medical device firm, Procyrion, Inc., reported the successful real-world application of its Aortix pump for the first time in February 2023. The advanced equipment is made to protect against acute kidney injury (AKI) in patients undergoing heart surgery. The Aortix pump is introduced through a catheter in the descending thoracic aorta, it enhances kidney blood flow while lessening the strain on the heart during the procedure. It accomplishes this by both improving renal and systemic blood circulation and diminishing the heart's strain, which is particularly useful for patients with weakened left ventricular function and kidney damage. The Aortix pump can deliver up to 5.0 liters of flow per minute and is designed for temporary use in operations like percutaneous coronary interventions (PCI).

What Are the Main Segments in the Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market covered in this report is segmented -

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Which Top Companies are Driving Growth in the Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Which Regions Will Dominate the Percutaneous Mechanical Circulatory Support Devices Market Through 2029?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.